Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

Second generation basal insulin in advancing T2D therapy

MAT-BH-2500630

Back to top
Privacy Notice Update | We have updated our Privacy Notice for Healthcare Professionals to improve your experience collaborating with us, maintain high standards of privacy and ultimately strengthen the trust you place in us. Key improvements include enhanced clarity on why and how Sanofi processes your personal data.
SitemapLegal noticePrivacy PolicyCookie PolicyContactAccessibility statement

© Sanofi 2004-2026 - All rights reserved

MAT-SA-2100978/V10/APR2026

Privacy Notice Update | We have updated our Privacy Notice for Healthcare Professionals to improve your experience collaborating with us, maintain high standards of privacy and ultimately strengthen the trust you place in us. Key improvements include enhanced clarity on why and how Sanofi processes your personal data.
SitemapLegal noticePrivacy PolicyCookie PolicyContactAccessibility statement
Back to top

© Sanofi 2004-2026 - All rights reserved

MAT-SA-2100978/V10/APR2026